Pasteur Institute's news

Filter news

AVATAR MEDICAL Team
News
09.02.2023
Innovation
AVATAR MEDICAL, laureate of the EIC Accelerator, a new step forward in bringing medical imaging at the heart of the surgical practice
AVATAR MEDICAL, spin-off from the Institut Pasteur and Institut Curie, two institutes with the Carnot label, was...
See the news
Macrophage humain infecté par le virus Lassa (Arénavirus)
News
06.01.2023
Innovation
Development of a pentavalent vaccine against New World arenaviruses
An Institut Pasteur team has successfully developed a pentavalent vaccine against the five pathogenic arenaviruses...
See the news
Anticorps SARS-CoV-2
News
07.12.2022
Innovation
SpikImm receives a major funding to accelerate the clinical and industrial development of its monoclonal antibodies against SARS-CoV-2
  SpikImm, a biotech company founded in 2021 by Truffle Capital in collaboration with the Institut Pasteur, has been...
See the news
microscope
News
19.07.2022
Innovation
A successful first edition of Pasteur Innov Day
See the news
microscope
News
07.06.2022
Innovation
Small/medium-sized companies in the healthcare sector: see you at Pasteur Innov’ Day!
Are you a small or medium-sized company in the healthcare sector and are you looking for a collaborator of choice to...
See the news
moderna
News
16.05.2022
Innovation
mRNA Access: researchers of the Institut Pasteur can benefit from Moderna's mRNA platform for global health
The Institut Pasteur and Moderna have signed a Master Material Transfer Agreement (MMTA) to enable researchers of the...
See the news
covid
News
12.05.2022
Innovation
SARS-CoV 2: A booster with a "Lenti-COVID" vaccine candidate induces protective immunity in the respiratory mucosa in a preclinical model
Scientist at the Institut Pasteur- TheraVectys Joint Laboratory have demonstrated the efficacy of their lentiviral...
See the news
microscope
News
12.05.2022
Innovation
SAVE THE DATE : Pasteur Innov’day - First edition July 7th, 2022!
Fundamentally applied! From basic research to product: the innovation potential of the Institut Pasteur’s continuum  ...
See the news
Le moustique Aedes aegypti est vecteur de la dengue, du chikungunya, de la fièvre jaune et de zika
News
28.02.2022
Innovation
Signing of an exclusive license agreement between the Institut Pasteur and Meletios Therapeutics for the development of a new class of antivirals
The exclusive worldwide license agreement signed between the Institut Pasteur and Meletios Therapeutics, a French...
See the news

Pages

Back to top